Skip to content

Clinical efficacy evaluation of electroacupuncture combined with PD-1 inhibitor in the treatment of advanced non-small cell lung cancer with ECOG2

Clinical efficacy evaluation of electroacupuncture combined with PD-1 inhibitor in the treatment of advanced non-small cell lung cancer with ECOG2

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000793
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-03-27
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Control group:Standard first-line treatment and sham electroacupuncture
Treatment group:Standard first-line treatment and electropuncture

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with stage ?B-? non-small cell lung cancer diagnosed by pathology or cytology; (2) Patients with negative driver gene mutation; (3) ECOG2 score; (4) PD-L1 expression level =1%; (5) Expected survival > 3 months; (6) The patient is willing to accept the treatment program and has good compliance.

Exclusion criteria

Exclusion criteria: (1) Patients with other malignant tumors in the past or at the same time within 5 years; (2) Serious heart liver kidney damage or other serious complications; (3) Exclude patients with central nervous system metastasis without systemic treatment; (4) Persons with mental disorders; (5) Have a history of multiple drug allergies allergic constitution; (6) Women who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Progression free survival;

Secondary

MeasureTime frame
Completion rate of first-line therapy;Immunologic function;TCM symptom score of lung cancer;Living quality;Objective remission rate;Security Index;Overall survival;

Countries

China

Contacts

Public ContactFanming Kong

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

kongfanming08@163.com28976533

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026